New hope for controlling cholesterol in dialysis patients

NCT ID NCT00858637

Summary

This study tested if a new drug called MCI-196 could lower bad cholesterol (LDL) in people with severe kidney disease who are on dialysis. It compared MCI-196 to a common cholesterol drug (simvastatin) and to a placebo (a dummy pill). The goal was to see if the new drug worked as well as or better than the standard treatment for managing this health risk.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Study site

    Brest, Belarus

  • Study site

    Grodno, Belarus

  • Study site

    Homyel, Belarus

  • Study site

    Minsk, Belarus

  • Study site

    Vitebsk, Belarus

  • Study site

    Gabrovo, Bulgaria

  • Study site

    Plovdiv, Bulgaria

  • Study site

    Sofia, Bulgaria

  • Study site

    Karlovac, Croatia

  • Study site

    Osijek, Croatia

  • Study site

    Esbjerg, Denmark

  • Study site

    Roskilde, Denmark

  • Study site

    Jakarta, Indonesia

  • Study site

    Malang, Indonesia

  • Study site

    Medan, Indonesia

  • Study site

    Palembang, Indonesia

  • Study site

    Tamanlarea Makassar, Indonesia

  • Study site

    Ashkelon, Israel

  • Study site

    Nahariya, Israel

  • Study site

    Bellano, Italy

  • Study site

    Catania, Italy

  • Study site

    Lecco, Italy

  • Study site

    Merate, Italy

  • Study site

    Milan, Italy

  • Study site

    Oggiono, Italy

  • Study site

    Riga, Latvia

  • Study site

    Valmiera, Latvia

  • Study site

    Kaunas, Lithuania

  • Study site

    Kedauniai, Lithuania

  • Study site

    Vilnius, Lithuania

  • Study site

    George Town, Malaysia

  • Study site

    Johor Bahru, Malaysia

  • Study site

    Kelantan, Malaysia

  • Study site

    Perak, Malaysia

  • Study site

    Bucharest, Romania

  • Study site

    Timișoara, Romania

  • Study site

    Singapore, Singapore

  • Study site

    Bangkok, Thailand

  • Study site

    Phitsanulok, Thailand

Conditions

Explore the condition pages connected to this study.